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Abstract
Background: Brucella is a facultative intracellular pathogen responsible for zoonotic disease brucellosis. Little is
known about the molecular basis of Brucella adherence to host cells. In the present study, the possible role of Bp26
protein as an adhesin was explored. The ability of Brucella protein Bp26 to bind to extracellular matrix (ECM)
proteins was determined by enzyme-linked immunosorbent assay (ELISA) and biolayer interferometry (BLI).
Results: ELISA experiments showed that Bp26 bound in a dose-dependent manner to both immobilized type I
collagen and vitronectin. Bp26 bound weakly to soluble fibronectin but did not bind to immobilized fibronectin. No
binding to laminin was detected. Biolayer interferometry showed high binding affinity of Bp26 to immobilized type
I collagen and no binding to fibronectin or laminin. Mapping of Bp26 antigenic epitopes by biotinylated
overlapping peptides spanning the entire sequence of Bp26 using anti Bp26 mouse serum led to the identification
of five linear epitopes. Collagen and vitronectin bound to peptides from several regions of Bp26, with many of the
binding sites for the ligands overlapping.
The strongest binding for anti-Bp26 mouse serum, collagen and vitronectin was to the peptides at the C-terminus
of Bp26. Fibronectin did not bind to any of the peptides, although it bound to the whole Bp26 protein.
Conclusions: Our results highlight the possible role of Bp26 protein in the adhesion process of Brucella to host
cells through ECM components. This study revealed that Bp26 binds to both immobilized and soluble type I
collagen and vitronectin. It also binds to soluble but not immobilized fibronectin. However, Bp26 does not bind to
laminin.
These are novel findings that offer insight into understanding the interplay between Brucella and host target cells,
which may aid in future identification of a new target for diagnosis and/or vaccine development and prevention of
brucellosis.
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Background
Brucellosis is one of the most common bacterial zoo-
notic diseases. This disease is caused by organisms be-
longing to the genus Brucella, which are facultative
intracellular Gram-negative bacteria. Brucellosis causes
significant economic losses in livestock production as a
result of abortion, loss in milk production, low fertility
rates and cost of replacement of animals in several de-
veloping countries [1, 2]. In addition, Brucella causes
chronic and debilitating diseases in human with no ef-
fective currently available vaccine [3].
The process of bacterial adherence to the host requires
a recognition system between bacterial surface ligands
and specific host cell receptors to achieve a proper bind-
ing and invasion [4]. Most pathogenic bacteria express
adhesins on their surfaces that mediate interaction with
host cell receptors [5]. These interactions lead to host
cell signaling events that may trigger the efficient inva-
sion of host cells by the bacteria. Furthermore, these
adhesins recognize many different host molecules, in-
cluding components of the extracellular matrix (ECM),
like collagen, vitronectin, and fibronectin [5, 6].
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Brucella are able to adhere and invade different cell
types and tissues [7] to accomplish this, Brucella express
bacterial surface molecules dedicated to the specific rec-
ognition of unique or common receptor components
present on host cells as well as in numerous tissues [8].
A great deal of information is available on the adher-
ence of many other pathogenic Gram-negative bacteria
such as enteropathogenic Escherichia coli, Bacteroides
fragilis, Yersinia pseudotuberculosis, Neisseria spp. as
well as Gram-positive bacteria like Staphylococcus spp.,
Streptococcus spp., with cells of the immune system, epi-
thelial cells and extracellular matrix components (ECM)
corroborating the importance of adhesion for pathogen-
esis [9–14].
Concerning Brucella species, the only published report
on adherence is for B. abortus, where ECM molecules
such as collagen, fibronectin, vitronectin, laminin and
chondroitin sulphate have been proposed to play an im-
portant role in Brucella spreading and invasion mecha-
nisms to host cells and tissues [8]. In addition, recent
work carried out on the identification of Brucella pro-
teins has shown their potential role in adhesion to vari-
ous host cell types. One of three identified Brucella
surface-associated protein candidates is a 41 kDa surface
protein (SP41) that is associated with bacterial adher-
ence and invasion of HeLa cells [15]. Two autotranspor-
ter proteins, OmaA and BmaC, of B. suis, have been
reported to influence survival of B. suis in the chronic
phase of infection in a murine model [16]. BmaC, a
monomeric autotransporter protein, has also been
shown to play a role in the adhesion of B. suis to the
ECM and non-phagocytic cells via fibronectin binding
[17]. Furthermore, another study focused on the devel-
opment of new vaccines or drugs to block the adhesion
step in the infection cycle [18, 19]. These studies indi-
cate that there is much more to explore regarding the
mechanisms underlying adhesion of Brucella to ECM
molecules.
The present study was undertaken to further study the
interaction of Brucella with ECM components using one
of the major outer membrane proteins of Brucella,
Bp26. The rationale behind choosing Bp26 is that pub-
lished data emphasize its particular usefulness as an
immunodominant target molecule for detection of anti-
Brucella antibodies of the infected animals. Additionally,
Bp26 can be used in the confirmatory differentiation of
serological responses of infected animals from those of
vaccinated ones. Mention should also be made that
Bp26 is conserved among different Brucella species [20].
Our results highlight the possible role of Bp26 protein
in the adhesion process of Brucella to host cells through
ECM components. These are novel findings that offer
insight into understanding the interplay between Bru-
cella and host target cells, which may aid in future
identification of a new target for diagnosis and/or vac-
cine development and prevention of brucellosis.
Results
Binding of Bp26 to ECM molecules
Apart from its role as a diagnostic antigen, the func-
tional role of Bp26 has not been explored. ECM compo-
nents constitute a diversity of possible receptor
structures for a wide variety of bacterial ligands. There-
fore, the rationale of this study was to explore if Bp26
would bind to ECM molecules.
In this study, the interaction of the Brucella Bp26 pro-
tein with a number of selected ECM molecules was car-
ried out to explore the possible role of Bp26 in the
adhesion process of Brucella to host cells through major
components ECM. We tested the ability of purified
Bp26 to bind to type I collagen, fibronectin, vitronectin
and laminin. Bp26 distinctly bound in a concentration
dependent manner to both immobilized and soluble type
I collagen and vitronectin in ELISA experiments (Figs. 1
and 2). Bp26 protein exhibited weak binding to soluble
but not to immobilized fibronectin (Figs. 1 and 2b).
However, it did not bind to laminin in either form (Fig.
1). In contrast to fibronectin and collagen, Bp26 was able
to bind to soluble vitronectin even at the very low con-
centration of 0.1 μg/ml) (Fig. 2).
The binding of Bp26 to the ECM matrix proteins was
further analyzed using biolayer interferometry. The
ECM proteins were immobilized onto the biosensors via
an amine-coupling reaction. Heat-inactivated bovine
serum albumin (BSA) was used as a reference control.
As shown in the Fig. 3, Bp26 displayed clear binding to
type I collagen giving a KD (dissociation constant) of
134.7 ± 1.4 nM, a ka (association rate constant) of 3.9 ×
103 ± 0.04 × 103 (1/Ms), and a kd (dissociation rate con-
stant) of 5.2 × 10− 4 ± 0.02 × 10− 4 (1/s). The coefficient of
determination R2 was 0.99. No significant binding of
Bp26 was observed to fibronectin or laminin (Fig. 3).
These observations are in line with the data obtained by
ELISA. Vitronectin was not included in the test due to
the Tris-containing sample buffer that obstructs amine-
coupling or biotin-labeling. Instead, we performed an-
other experiment with biotinylated Bp26 captured on SA
sensors and vitronectin testes as a soluble analyte. We
detected significant binding of vitronectin to Bp26 with
KD of 43.8 ± 0.8 nM in a 2:1 Heterogeneous Ligand bind-
ing model (Fig. 3e).
Mapping of the antigenic epitopes of Bp26
A step towards understanding the structure-function re-
lationships of Bp26 is mapping of its antigenic epitopes.
In this work, biotinylated synthetic peptides spanning
the entire amino acid sequence of Bp26 were used to
identify immunogenic regions. The use of biotinylated
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synthetic peptides has some benefits, which include: i)
the method being very flexible, and after dissolving, each
peptide can be immobilized individually onto
streptavidin-coated microtiter plates for ELISA; ii) the
possibility of several streptavidin-coated plates sets being
prepared simultaneously, and stored at 4 °C for further
use; iii) the method allowing the use of fresh synthetic
peptide for each reaction; iv) allowing the peptides to be
used in binding assays to immobilized fragments and de-
tected with labelled streptavidin; and v) avoiding toxic
protein production. Bp26 has been shown to be toxic in
E. coli [21] thus the use of synthetic peptides to map the
epitopes shown in this study has an advantage to avoid
such toxicity.
Using biotinylated Bp26-specific peptides and Bp26
mouse serum led to the identification of five linear epi-
topes on the Bp26 protein. The epitopes were found to
reside at the N-terminus, corresponding to amino acid
positons 51–65, 96–135,121–135 and at the C-terminus,
corresponding to amino acid positions 226–250 of Bp26.
The strongest binding affinity was for peptides from the
C-terminus of Bp26 (Fig. 4a).
Identification of type I collagen binding sites on Bp26
Identification of proteins binding motifs is useful for
understanding the interaction mechanisms and for de-
veloping inhibitors. Therefore, another objective in
this study was to identify Bp26 binding motifs for
type I collagen and vitronectin. We tested the binding
of type I collagen to the immobilized biotinylated
peptide. Altogether, nine binding regions were identi-
fied. Collagen binding sites were found to reside at
the N-terminus, corresponding to amino acids
residues 51–65, 96–135 and most prominently at the
C-terminal peptides, corresponding to the region
226–250 of Bp26 (Fig. 4b).
Identification of vitronectin binding sites on Bp26
The vitronectin binding sites in Bp26 were tested as
above and found to reside at the N-terminus, corre-
sponding to amino acids 46–65, 96–115, 146–160 and at
the C-terminus, corresponding to amino acid positions
176–190, 231–250 (Fig. 4c).
Interestingly, type I collagen, vitronectin and the
mouse serum all share the binding site at the C-
terminus of Bp26. However, fibronectin did not bind to
any of the peptides, although it did bind weakly to the
whole Bp26 protein.
Mapping of binding sites to Bp26 structure
To gain insight into the binding sites for the ECM mole-
cules and anti-Bp26 mouse serum, we mapped the bind-
ing peptides onto the crystal structure of Bp26
(PDB4HVZ) [22]. Bp26 forms a barrel-like homohexade-
cameric complex (Fig. 5a). The binding sites for colla-
gen, vitronectin and the mouse serum map mainly to
the two β-sheets at either end of the monomer (Fig. 5b-
d). When mapped on the complex, the N- and C-
termini of the monomers line the rims of the barrel, and
are thus partially exposed (Fig. 5e).
Discussion
Bp26 is a Brucella protein that attracted many re-
searchers for its candidacy as a diagnostic protein that
differentiates between naturally infected and vaccinated
animals. Apart from this, we have not found in the
Fig. 1 Binding of Bp26 protein to immobilized ECM components. Depiction of binding of collagen type I, fibronectin, vitronectin, laminin and
bovine serum albumin (negative control) immobilized on a microtitre ELISA plate after overnight incubation at 4 °C with Bp26 protein (5 μg/ μl).
Different concentrations of the molecules were detected by peroxidase reaction using anti-Bp26 mouse serum (diluted 1:1000) and rabbit anti-
mouse IgG peroxidase conjugate and peroxidase substrate. The measures represent the average of each independent test after subtraction of the
background value obtained in the absence of each the ECM molecules. Bars indicate standard errors presented as the means ± SD for each of
the four tests
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literature reports about its function(s). Therefore, the
major objective of this study was to study the interaction
of the Brucella Bp26 protein with a number of selected
ECM molecules. Two approaches were explored i)
ELISA experiments showed that Bp26 bound in a dose-
dependent manner to both immobilized type I collagen
and vitronectin. Bp26 bound weakly to soluble fibronec-
tin but did not bind to immobilized fibronectin. No
binding to laminin was detected. ii) Biolayer interferom-
etry was used as confirmatory approach to ELISA
results. This approach showed high binding affinity of
Bp26 to type I collagen and vitronectin but no binding
to fibronectin or laminin. Only one study showed that B.
abortus binds to fibronectin and vitronectin but to a
lesser extent to collagen, laminin and chondroitin
sulphate [8]. Our findings suggest that Bp26 may be in-
volved in the adhesion process of Brucella to its host
through collagen and vitronectn but other surface mole-
cules may be responsible for the recognition of fibronec-
tin and laminin. However, this study is limited to an
Fig. 2 Binding of Bp26 protein to soluble ECM components. Representation of different concentrations of collagen type I (a), fibronectin (b), and
vitronectin (c) after incubation with immobilized Bp26 protein (5 μg/ μl) on ELISA microtiter plates and detection of binding affinity. Binding of
the molecules was detected by peroxidase reaction using MABs specific for each molecule, followed by peroxidase conjugate and substrate as
detailed in Materials & Methods. The optical density values of the negative controls were subtracted from the binding values. Each value
represents the mean ± SD for each of four independent tests. The ECM molecules concentrations are expressed in μg ml − 1
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in vitro situation and further study should be conducted
with bp26 mutant versus a wild type Brucella to give a
better insight into how Bp26 will interacts with the ECM
in vivo.
The above results encouraged us to study the
structure-function of Bp26. We constructed biotinylated
synthetic peptides spanning the entire amino acid se-
quence of Bp26 to identify immunogenic and binding
sites regions of Bp26.
Anti-Bp26 mouse serum, collagen and vitronectin
bound to peptides from several regions of Bp26, with
many of the binding sites for the ligands overlap-
ping.The strongest binding for all tested ligands was to
the peptides at the C-terminus of Bp26. Fibronectin did
not bind to any of the peptides, although it bound
weakly to the whole Bp26 protein.
A closer look at the reacting peptides, peptide
96LQTGGINIQPIYVYP110 showed strong reactivity
with collagen, vitronectin and anti-Bp26 mouse anti-
body. This peptide overlaps with peptide 101INIQPIY-
VYPDDKNN115 which did not react with collagen or
anti-Bp26 mouse sera (Table 1). This suggests that
amino acids LQTGG are crucial for both collagen and
anti-Bp26 mouse sera recognition. On the other hand,
vitronectin bound to both peptides which suggest that
amino acids 111DDKNN115 are crucial for the recogni-
tion of vitronectin. Our results are in agreement with
[23] where they used 28 overlapping peptides spanning
the entire sequence of Bp26 and a series of monoclonal
antibodies. Their study identified two linear epitopes at
amino acid sequences 93DRDLQTGGI101 and
104QPIYVYPD111. This is similar to our results since
anti-Bp26 mouse serum used in this study recognized
epitopes in the same region. When aspartic acid at posi-
tions 93 and 95 was substituted with Asparagine (D93N
and D95N), the binding was lost [23]. Interestingly, a
Fig. 3 Biolayer interferometry analyses of Bp26 binding to ECM
proteins. Heat-inactivated BSA (a), collagen I (b), fibronectin (c), and
laminin (d) 521, 10 μg/ml in 10 mM sodium acetate, pH 4 (ForteBio),
were respectively coupled onto AR2G sensors (ForteBio) with
immobilization levels between 1.5 to 2.0 nm. For kinetics analysis,
Bp26 was diluted in the running kinetics buffer (ForteBio) with
additional 0.15 M NaCl to reduce the non-specific binding of Bp26
to the reference sensor. The concentrations tested were 0, 125, 250,
500, and 1000 nM. All the experiments were performed at 30 °C,
including association for 5 min, and dissociation for 15 min. The raw
data were processed by reference subtraction and data correction. E.
Biolayer interferometry analyses of vitronectin binding to
immobilized Bp26 Bionylated Bp26 was captured onto SA sensors
(ForteBio) with immobilization levels of 2.0 nm. Vitronectin was
diluted in the running kinetics buffer (ForteBio) to the
concentrations of 75, 300, 600, and 1200 nM. All the experiments
were performed at 30 °C, including association for 5 min, and
dissociation for 15 min. The raw data were processed by reference
subtraction and data correction.
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Fig. 4 Epitope mapping of Bp26 a: Reactivity of anti Bp26 mouse serum to Bp26 synthetic biotinylated peptides: Reactivity of anti Bp26 mouse serum with
synthetic biotinylated BP26-specific peptides was determined using the ELISA assay as detailed in the Materials & Methods. The absorbance readings are
averages from four experiments after subtracting the mean control values (~ 0.109). b & c: Identification of collagen and vitronectin binding sites on Bp 26.
Immobilized biotinylated peptides were used for identifying binding sites of collagen and vitronectin on Bp26 after incubation with collagen type I, 100 μg/
ml (b) and vitronectin, 1 μg/ ml (c). Binding was detected with peroxidase reaction using anti-collagen or anti-vitronectin Mabs (1:1000 dilution in PBS-T)
followed by incubation with HRP goat anti-mouse IgG conjugate and peroxidase substrate. The reaction at A450 was recorded with a multi-scan
spectrophotometer. Control values were subtracted from the binding values
ElTahir et al. BMC Molecular and Cell Biology           (2019) 20:55 Page 6 of 12
closer look at Bp26 amino acids sequence, we noticed a
motif structure IYVYP or similar is present in most of
the binding sites identified in this study. Three of these
amino acids residues are hydrophobic (IVP), which sug-
gests that Bp26 uses its hydrophobic residues to ensure
long term binding to some ECM. Hydrophobic interac-
tions are usually considered to be important in bacterial
adhesion [24, 25].
Seco-Mediavilla et al. [20] studied epitope mapping of
Bp26 using a panel of anti-Bp26 MAbs and fragments of
Bp26 synthesized as fusion proteins in E. coli. Common
to all fusion proteins used was the C-terminal region be-
tween amino acids 220–250. They showed that all Bp26
fragments reacted in colony blotting with anti-Bp26
MAb. However, in western blotting analysis, only Bp26
regions, between amino acids residues 1–191, and 55–
152 reacted with more MAbs. Interestingly, in this study,
parts of these regions were identified by collagen, vitro-
nectin and or anti-Bp26 mouse antibody (Table 1 re-
gions 51–65, 96–110 and 121–135).
Also, Seco-Mediavilla et al., [20] tested fragments of
Bp26 synthesized as fusion proteins in E. coli with Bru-
cella-free and Brucella-infected sheep sera. They con-
cluded that the region of Bp26 between residues 55 and
152 might provide better specificity results than the entire
recombinant Bp26, avoiding false-positive reaction with
sera from Brucella-free sheep, for the serological diagnosis
of sheep brucellosis caused by B. melitensis or B. ovis.
Moreover, they showed that Bp26 fragment in E. coli be-
tween residues 220–250 did not react with Brucella in-
fected sera, and they concluded that this region would not
be useful for the serological diagnosis of sheep brucellosis.
However, the present study shows that the strongest anti-
genic region on Bp26 on which most of the binding oc-
curred is at in C-terminus, between residues 226–250.
Their finding maybe explained by the fact that Bp26 is
toxic and the region is so short and might have undergone
conformational changes during expression that prevented
it from being recognized and we may have avoided such
toxicity with our biotinylated synthetic approach.
Fig. 5 Mapping of binding sites to Bp26 structure. a Structure of channel-like hexadecameric Bp26 shown in cartoon representation. Each
monomer is coloured differently. b Binding sites for mAb mapped on Bp26 monomer structure. Regions corresponding to high-binding peptides
from Fig. 4a are shown in red. c Binding sites for collagen mapped on Bp26 monomer structure. Regions corresponding to high-binding peptides
from Fig. 4b are shown in red. d Binding sites for vitronectin mapped on the Bp26 monomer structure. Regions corresponding to high-binding
peptides from Fig. 4c are shown in red. e Binding sites for collagen mapped onto hexadecameric Bp26 complex. The structure is viewed from
the side on the right and from the bottom (i.e. through the channel) on the right. The regions corresponding to the high-binding peptides from
Fig. 4b have been coloured in red for the monomers in the lower half of the complex. The structure shows the C-termini of the proteins are
arranged along the rim of the channel. All structures in the figure were prepared with PyMOL (Schroedinger) and are based on the Bp26 crystal
structure (PDB ID: 4HVZ)
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An issue with Bp26 acting as an adhesin is that
most of the binding motifs uncovered by our peptide
array experiments are largely buried in the complex
structure. However, it should be noted that the com-
mon high-binding C-terminal region is located at the
rim of the barrel and is therefore at least partially ex-
posed to the solvent (Fig. 5e). It is thus conceivable
that the main binding site is the rim of the barrel,
where multiple binding epitopes would provide co-
operative binding to ECM proteins. Another alterna-
tive is that, upon release from the cell and when local
protein concentrations drop, Bp26 monomer dissoci-
ates from the complex allowing binding via previously
buried epitopes.
Table 1 list of Bp 26 biotinylated synthetic BP26 peptides. The 15mer peptides overlap with 10mer. Yellow color: The peptides that
reacted strongly with anti-Bp26 mouse serum. Green color: The peptides that reacted with anti-bp26 mouse serum, collagen and
vitronectin. Red color: peptides that reacted with collagen and vitronectin. Pink color: peptides that reacted with collagen only. Light
blue: peptides that reacted with vitronectin only
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Another issue with the adhesin function of Bp26 is its
subcellular localization. Though described as a surface-
exposed outer membrane protein (Omp28) of Brucella
[26] other studies indicated a periplasmic localization for
Bp26 [27, 28] How a soluble protein apparently located
in the periplasm could mediate adhesion is not clear at
this moment. One possibility is that Bp26 is secreted
outside the cell by a yet unidentified secretion system.
Another is that Bp26 is released from the cell upon lysis,
and then acts as a “common good” allowing un lysed
bacteria to adhere to host cells and tissues via bridging
Bp26.
Interestingly, the multivalent adhesion molecule 7
(MAM7) mirrors the situation of Bp26. MAM7 was re-
ported to be an outer membrane protein that mediates
initial attachment of a number of Gram-negative patho-
gens to host cells [29] However, recent work has shown
that in laboratory E. coli, where MAM7 is called YebT,
the protein is periplasmic [30] Like Bp26, YebT also
forms a large multimeric complex suggested to function
in lipid transport between the outer and inner mem-
branes. How Bp26 and YebT/MAM7 carry out their dual
functions as periplasmic proteins and cell surface adhe-
sins remains to be discovered.
Taken together, our data contribute to furthering our
knowledge of the molecular mechanisms involved in the
interaction of Brucella Bp26 with host ECM molecules,
which assists in understanding at least in part how Bru-
cella adhere and disseminate within the host, and to
identify a new target for vaccine development and pre-
vention of brucellosis.
Conclusion
The results of this work highlight the role of Bp26 pro-
tein in the binding of Brucella to ECM molecules
in vitro, which may result in the attachment and spread-
ing of the organism within the host. The most important
conclusions of this work are the followings.
 Bp26 binds to both immobilized and soluble type I
collagen and vitronectin.
 Bp26 binds weakly to soluble but not immobilized
fibronectin
 Bp26 does not bind to laminin in any form.
 Epitope mapping of Bp26 led to the identification of
four linear antigenic regions on Bp26, covering
amino acids 51–65, 96–110, 121–135, and 226–250.
 Vitronectin recognized an additional antigenic
region on Bp26 peptides between residues 146–160
and176–190
These are novel findings that offer new insight into
understanding the interplay between Brucella and host
target cells.
Methods
Recombinant Bp 26 protein
Purified recombinant Bp26 was a kind gift from Profes-
sor David Pascual at the University of Florida College of
Veterinary Medicine USA. The construction and de-
tailed purification steps are described in their study [31].
The lyophilized recombinant Bp26 protein (> 1.0 mg/ml)
was re-suspended in 0.5 ml sterile water. A commercial
Bp26 for BLI analysis was purchased from RayBiotech.
Extracellular matrix molecules used in the study
Collagen type I (100 mg) (from rat tail), lyophilized fi-
bronectin (5 mg) (from rat plasma), vitronectin (50 μg)
(from human plasma) and laminin (0.6 mg) (from hu-
man fibroblast) (all from Sigma) were dissolved in 1ml
deionized water according to the manufacturer’s
instruction.
The ECM proteins used in BLI measurements are rat
collagen I, 4 mg/ml in 50mM acetic acid (Thermo
Fisher Scientific), human fibronectin, 1 mg/ml, in PBS
(Sigma), Laminin 521, 0.1 mg/ml in PBS (BioLamina),
vitronectin, 0.22 mg/ml in TBS (a gift from late Dr. Ru-
pert Timpl, Max Planck Institute of Biochemistry), and a
reference protein, heat-shocked BSA, 10 mg/ml in dH2O
(Sigma).
Antibodies used in the study
Anti-Bp26 mouse serum was kind gift from Professor
David Pascual at the University of Florida College of
Veterinary Medicine USA. The pooled sera were derived
from a previous published study [31], where mice were
nasally vaccinated with recombinant Bp26 co-
administered with the adjuvant, cholera toxin.
The antibodies used for detection were peroxidase-
conjugated rabbit anti-mouse secondary antibody (Sigma
Cat. No. A9044), monoclonal anti-collagen type I (Sigma
Cat. No. C2456), monoclonal anti-fibronectin (Sigma
No. F7387), monoclonal anti-vitronectin. (Sigma Cat. No
V7881), and monoclonal anti-laminin. (Sigma Cat. No.
L8271).
Binding of Bp26 protein to immobilized ECM
Binding of immobilized ECM molecules to Bp26 protein
was studied by a standard ELISA procedure. Briefly, 96-
well polystyrene micro plates were coated with 100 μl of
four different concentration of collagen, fibronectin,
vitronectin, or laminin (1, 0.5, 0.25 and 0.1 μg/ ml PBS-
T). The plates were then incubated at 4 °C overnight.
Plates were then washed four times with PBS-T and
blocked with 3% BSA/PBS for one hour at room
temperature (RT). After washing four times with PBS-T,
the plates were incubated with 100 μl of Bp26 protein
(100 μg/ ml in 3% BSA-PBS) overnight at 4 °C. The
plates were then washed four times with PBS-T, and
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incubated overnight at 4 °C with 100 μl of anti Bp26
mouse serum (1:1000 dilution in 3% BSA-PBS), followed
by incubation for 1 h at RT followed by washes as above
and the incubation with 1:5000 dilution of peroxidase-
conjugated rabbit anti-mouse secondary antibody in 3%
BSA-PBS for 1 h. After washings, the presence of
peroxidase was detected with 100 μl substrate solution
consisting of 50 mg of ABTS [2,2-Azino-di-(3-ethyl-
benzo-thiazoline) sulphonate, (SIGMA-Aldrich cat. No.
A3219) for 10 min. The reaction was stopped by adding
50 μl 1M HCl. The absorbance at 450 nm was measured
with a multi-scan spectrophotometer (Labsystems).
The experiments were performed four times. The
background control plates were treated identically, ex-
cept that primary or secondary antibodies were omitted
and wells were incubated with buffer instead. In another
control, 100 μl of 2%BSA/PBS was immobilized on the
wells, and treated as above.
Binding of Bp26 protein to soluble ECM molecules
Binding of Bp 26 protein to soluble ECM was studied
using ELISA. Briefly, 96-Microtiter plate wells were
coated with 100 μl of Bp26 protein (5 μg/ μl) incubated
overnight at 4 °C. Washing and blocking steps were done
as described above. 100 μl of different concentrations of
each ECM molecule (collagen 1000, 100, 50, and 10 μg/
ml; fibronectin 100, 50, 25 and 10 μg /ml; vitronectin 1,
0.5. 0.25 and 0.1 μg/ml; laminin 10, 5, 2.5 and 1 μg/ml,
all in PBS-T) were incubated in Bp26-coated plates over-
night at 4 °C. After washing, the plates were incubated
for 1 h at 37 °C with 100 μl of 1:1000 dilutions of anti-
ECM Mabs (anti-collagen, anti-fibronectin, anti-
vitronectin, and anti-laminin). Then the plates were
washed and incubated for 1 h at RT with a 1:5000 dilu-
tion of peroxidase-conjugated rabbit anti-mouse second-
ary antibody. Detection of bound ECM molecules was
done as above. The experiments were repeated four
times. Control plates were treated as above.
Biolayer interferometry
Biolayer interferometry analysis was performed using an
Octet Red 384 instrument (FortéBio). Type I collagen, fi-
bronectin, recombinant human laminin 521, and heat-
inactivated BSA were immobilized separately onto
AR2G biosensors (FortéBio) at pH 4 according to the in-
struction from the manufacturer. The interactions be-
tween Bp26 and the immobilized proteins were
determined using a defined method with the following
set up: (1) baseline stabilization in kinetics PBS buffer
(FortéBio) for 2 min; (2) association with serially diluted
Bp26 in the same buffer for 5 min; (3) dissociation in the
same buffer for 15 min; (4) regeneration twice with 10
mM glycine, pH 2 for 30 s. The binding data were fitted
globally with a 1:1 model and the kinetic parameters (ka,
kd, KD) were calculated using the HT data analysis soft-
ware (FortéBio).
For binding of ECM proteins to immobilized Bp26,
the Bp26 was first reacted with EZ-link NHS-PEG4-Bio-
tin (Thermo Fisher) using 1:1 ratio at room temperature
for 30 min. The excess reagent was removed using a
Zeba™ Spin Desalting Column, 7 K MWCO (Thermo
Scientific). The biotinylated Bp26 was then captured to
SA sensors using the Octet Red 384 instrument accord-
ing to the instruction provided by the manufacture.After
the immobilization step five concentrations of vitronec-
tin were tested in parallel for binding to the Bp26. All
measurements were performed in PBS Kinetics Buffer
(ForteBio) at 30 °C in 384-well Tilt microplates (Forte-
Bio). Data were analyzed using a 2:1 Heterogeneous Lig-
and interaction model using a Octet Data Analysis High
Throughput (HT) software 11.0.
Synthetic biotinylated Bp26-specific peptides
A set of 49 biotinylated synthetic peptides was pur-
chased from GL Biochem Shanghai Ltd. Company
(China) (Table 1). The peptides (15 residues long, except
the last peptide which was 10 residues long), cover the
entire Bp26 protein sequence of Brucella melitensis 16
M. The biotin residue in each peptide is located in the
amino-terminus, separated from the 15-mer peptide by a
two amino-acid (methionine, glycine) spacer (Biotin-
MG-15-mer). The peptides overlap each other by 10
amino acids; thus, each peptide advances along the se-
quence by 5 residues.. Dissolving, storage and handling
of the peptides were done according to the manufac-
turer’s instructions.
The peptides, ca. 0.9 μmoles each, were shipped as dry
powder. The peptides were dissolved into 200 μl of di-
methyl sulfoxide. After dissolving, the peptides were
stored at − 20 °C. The peptides were diluted according to
manufacturer’s instructions with PBS-T to give a work-
ing concentration of ca. 9 μM for each peptide.
Preparation of streptavidin coated plates and
immobilization of the biotinylated peptides
Microtiter plates were coated with streptavidin (Sigma
cat. No S6940) dissolved in water to a working solution
of 5 μg/ml. 100 μl was added to each well and the plates
were incubated at 37 °C overnight and exposed to air to
allow the solution to evaporate to dryness. The plates
were washed by flooding the wells with PBS-T, then vig-
orously flicking the solution from the wells. The washing
steps were repeated four times, and then the excess solu-
tion was removed from the wells by slapping the plates
down on a bench top covered with paper towels. For
convenience, several sets of streptavidin-coated plates
were prepared at the same time and stored in sealed
plastic bags at 4 °C till needed.
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The wells were blocked with 200 μl of PBS/T, incu-
bated for one hour at RT and after washing, 100 μl ali-
quots of the diluted peptide solutions were pipetted into
the pre-determined well positions of the streptavidin-
coated plates. The binding reaction was allowed to
proceed with gentle shaking for 1 h at RT. After incuba-
tion, the excess solution was flicked out and the plates
were washed four times in PBS-T. Several plates were
prepared at the same time, dried at 37 °C as above and
then stored at 4 °C until used later.
Epitope mapping of Bp26 using ELISA and immobilized
biotinylated peptides
In general, the assay followed the instructions for epi-
tope mapping given by the supplier of the biotinylated
peptides. Anti-Bp26 mouse serum was diluted 1:10 in
PBS-T and then incubated on the immobilized biotinyl-
ated peptide set overnight at 4 °C. Bound mouse serum
was detected using peroxidase-conjugated goat anti-
mouse immunoglobulin diluted 1:1000 in PBS-T. The
secondary antibody was incubated for 1 h at RT. After
washings, the presence of peroxidase was detected as
above. The absorbance at 405 nm was measured above.
The experiments were performed in duplicate. The
background control plates were treated identically ex-
cept that instead of the primary antibodies the wells
were incubated only with buffer.
Binding of ECM molecules to immobilized biotinylated
Bp26 peptides
Immobilized biotinylated peptides were blocked with 2%
Bovine serum albumin (BSA) in PBS for one hour at
room temperature. After washing with PBS, collagen
type I (100 μg/ ml), vitronectin (1 μg/ ml), or fibronectin
(50 μg/ ml), were incubated on the immobilized peptide
set overnight at 4 C. Bound ECM were detected using
anti-collagen, anti-vitronectin or anti-fibronectin Mabs
(1:1000 dilution in PBS-T) and then with goat anti-
mouse IgG conjugated to horseradish-peroxidase (HRP;
Sigma). The presence of peroxidase was detected as
above. A450 was recorded with a multi-scan spectropho-
tometer. Control wells were treated the same way, ex-
cept ECM, anti-ECM Mab, or HRP-goat anti-mouse
conjugate was omitted.
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